Profil
Jesus E.
Gonzalez is currently the Chief Scientific Officer at Avelas Biosciences, Inc. He previously worked as the Senior Director-Biology at Vertex Pharmaceuticals, Inc. and as the Director-Ion Channels at Aurora Biosciences Corp.
He completed his undergraduate degree at Rice University and his doctorate at Princeton University.
Postes actifs de Jesus E. Gonzalez
| Sociétés | Poste | Début |
|---|---|---|
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Directeur Technique/Scientifique/R&D | 19/10/2010 |
Anciens postes connus de Jesus E. Gonzalez
| Sociétés | Poste | Fin |
|---|---|---|
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Corporate Officer/Principal | - |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | - |
Formation de Jesus E. Gonzalez
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Aurora Biosciences Corp.
Aurora Biosciences Corp. BiotechnologyHealth Technology Designs and develops proprietary drug discovery systems, services and technologies | Health Technology |
Rice University
Rice University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avelas Biosciences, Inc.
Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Develops integrated suite of therapeutic and imaging agents for treatment of cancer | Health Services |
















